For US residents only.

RYDAPT IS NOW APPROVED
PATIENT INFORMATION for RYDAPT® (midostaurin) capsules:

What is RYDAPT? RYDAPT is an oral prescription medicine used to treat adults:

  • newly diagnosed with a certain type of acute myeloid leukemia (AML), in combination with certain chemotherapy medicines
    • You...
See More
Approved Use:

RYDAPT is an oral prescription medicine used to treat adults:

  • newly diagnosed with a certain type of acute myeloid leukemia (AML), in combination with certain chemotherapy medicines
    • Your healthcare provider will perform a test to make sure RYDAPT is right for you.
  • with aggressive system...
See More
Learn More About

Treatment Information

Learn more about a newly approved treatment for patients with newly diagnosed FLT3-mutated acute myeloid leukemia and for patients with any of 3 types of systemic mastocytosis (SM).*

Learn More
Learn More About

Patient
Support

Novartis is committed to helping patients gain access to the treatment they need. Click below for more information about how to access RYDAPT support programs.

Learn More

*Includes aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL), collectively referred to as advanced SM.